Overview
Hypoplastic aortoiliac syndrome (HAIS) is characterized by a small infrarenal aorta and hypoplastic iliofemoral arteries, predominantly affecting young women, often complicated by advanced atherosclerotic disease 1.Diagnosis
Small infrarenal aorta and hypoplastic iliofemoral arterial system identified via imaging (e.g., angiography) 1.
Elevated ankle-brachial index (ABI) discrepancy indicative of arterial insufficiency 1.
Common comorbidities include hyperlipidemia (mean cholesterol 287 mg/dl) 1.Management
First-line treatment: Percutaneous intervention (e.g., angioplasty, stenting) for revascularization 1.
Post-procedural monitoring: Regular follow-up to assess ABI and detect restenosis 1.
Management of complications: Address groin hematomas and thrombosis with appropriate medical intervention 1.
Adjunctive therapies: Lipid management to control hyperlipidemia (specific drug classes/doses not detailed) 1.Special Populations
Elderly: Not specifically addressed in the provided abstracts 1.
Comorbidities: Patients with HAIS less likely to have coronary disease and diabetes compared to general AoI patients, suggesting tailored cardiovascular risk management 1.Key Recommendations
Consider percutaneous intervention as a viable alternative to surgical revascularization for HAIS, achieving satisfactory long-term outcomes 1 (Evidence: Moderate).
Monitor patients post-intervention with regular ABI assessments to manage restenosis effectively 1 (Evidence: Moderate).
Implement aggressive lipid management in HAIS patients due to high prevalence of hyperlipidemia 1 (Evidence: Expert opinion).References
1 Walton BL, Dougherty K, Mortazavi A, Strickman N, Krajcer Z. Percutaneous intervention for the treatment of hypoplastic aortoiliac syndrome. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2003. link